RISANKIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 05:35:15 GMT 2023` Edited by `admin` on `Sat Dec 16 05:35:15 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	90ZX3Q3FR7
Record Status	`Validated (UNII)`
Record Version

Download

Related Record	Type

Name

Type

Language

RISANKIZUMAB

Official Name

English

RISANKIZUMAB [USAN]

Common Name

English

BI-655066

Brand Name

English

655066-01

Code

English

ABBV-066

Code

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 23 SUBUNIT P19) (HUMAN-MUS MUSCULUS HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS .KAPPA.-CHAIN, DIMER

Systematic Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL23A (INTERLEUKIN 23 SUBUNIT ALPHA, IL-23A, IL23 SUBUNIT P19, IL23P19)), HUMANIZED MONOCLONAL ANTIBODY

Common Name

English

RISANKIZUMAB [JAN]

Common Name

English

RISANKIZUMAB [MI]

Common Name

English

Risankizumab [WHO-DD]

Common Name

English

risankizumab [INN]

Common Name

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN INTERLEUKIN-23 SUBUNIT ALPHA (IL-23-A, INTERLEUKIN-23 SUBUNIT P19, IL-23P19))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-449) (HUMANIZED VH (HOMO SAPIENS IGHV1-69*08 (79%) (IGHD)-IGHJ6*01 (91%)) (8.8.13) (1-1

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C20401

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

FDA ORPHAN DRUG

544716

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

NCI_THESAURUS

C574

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

Code System Code Type Description

WIKIPEDIA

Risankizumab

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

CAS

1612838-76-2

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

MERCK INDEX

m12140

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

DRUG BANK

DB14762

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

SMS_ID

100000169020

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

FDA UNII

90ZX3Q3FR7

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

EVMPD

SUB182635

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

LACTMED

Risankizumab

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

INN

10128

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

RXCUI

2166040

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

RXCUI

2166132

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

ALTERNATIVE

DRUG CENTRAL

5337

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

NCI_THESAURUS

C152227

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

USAN

EF-54

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

DAILYMED

90ZX3Q3FR7

Created by admin on Sat Dec 16 05:35:15 GMT 2023 , Edited by admin on Sat Dec 16 05:35:15 GMT 2023

PRIMARY

From	To
1_22	1_96
1_147	1_203
1_264	1_324
1_370	1_428
2_22	2_96
2_147	2_203
2_264	2_324
2_370	2_428
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194
1_223	3_214
2_223	4_214
1_229	2_229
1_232	2_232

Glycosylation Type

MAMMALIAN

Glycosylation Link Type	Site
N	1_300
N	2_300

Related Record Type Details


					5OL0CTF85B

INTERLEUKIN-23 SUBUNIT ALPHA

TARGET -> INHIBITOR

RISANKIZUMAB-RZAA

SUB_CONCEPT->SUBSTANCE

Amount:

Related Record Type Details


					90ZX3Q3FR7

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:NON-GLYCOSYLATED(CALCULATED)	CHEMICAL